NUVL compared with LRMR: revenue, margins and what each company keeps, and the suppliers and customers both name

NUVLNuvalent, Inc.

Mkt capRevenueRevenue

LRMRLarimar Therapeutics, Inc.

Mkt capRevenueRevenue

Compare

NUVLNuvalent, Inc.

LRMRLarimar Therapeutics, Inc.

Price

Mkt cap

Revenue

Revenue flow

Not investment advice. Not a broker-dealer. Indices shown as ETF proxies. Supply-chain data CC BY 4.0; market data not redistributable.

Listed on One’s Vibe · live-checked · Oct ’26

NUVLNuvalent, Inc.

123.96▲+0.02%· post 123.96

Mkt cap$9.8B

LRMRLarimar Therapeutics, Inc.

2.47▼−7.49%· post 2.51

ClosedOct 30 '26

Mkt cap$256.6M

Compare

ClosedOct 30 '26

NUVLNuvalent, Inc.

LRMRLarimar Therapeutics, Inc.

123.96▲+0.02%post 123.96

Price

2.47▼−7.49%post 2.51

$9.8B

Mkt cap

$256.6M

NUVL123.96▲+0.02%vsLRMR2.47▼−7.49%ClosedOct 30 '26

rebased to 0%

NUVL, solidLRMR, dashed

NUVL: latest quarter not drawable. LRMR: latest quarter not drawable.Method ›

direct ties · both sidesSources ›

direct ties · both sides

No disclosed counterparties: NUVL, LRMR.

Role chip = supplier or customerSource: SEC EDGAR